129888-60-4 Usage
General Description
N-BOC-3-MESYLOXYPIPERIDINE is a chemical compound that belongs to the piperidine family. Its molecular structure consists of a piperidine ring with a BOC (tert-butoxycarbonyl) protective group at the nitrogen atom and a mesyloxy group attached to the piperidine ring. The BOC protective group is commonly used in organic synthesis to protect amines from unwanted reactions, while the mesyloxy group is a leaving group that can be easily substituted with other functional groups. N-BOC-3-MESYLOXYPIPERIDINE has applications in organic chemistry as a building block for the synthesis of various pharmaceuticals, agrochemicals, and other fine chemicals. Additionally, N-BOC-3-MESYLOXYPIPERIDINE is often used as a reagent in the synthesis of complex molecules due to its versatile reactivity and ease of manipulation.
Check Digit Verification of cas no
The CAS Registry Mumber 129888-60-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,8,8 and 8 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 129888-60:
(8*1)+(7*2)+(6*9)+(5*8)+(4*8)+(3*8)+(2*6)+(1*0)=184
184 % 10 = 4
So 129888-60-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H21NO5S/c1-11(2,3)16-10(13)12-7-5-6-9(8-12)17-18(4,14)15/h9H,5-8H2,1-4H3
129888-60-4Relevant articles and documents
Compound used as RET kinase inhibitor and application thereof
-
Paragraph 0253-0257, (2021/07/01)
The invention relates to a compound used as an RET kinase inhibitor and application thereof, wherein the compound has a structure as shown in a formula F, has good inhibition capability on RET kinase, and has good pharmacodynamic and pharmacokinetic performance and lower toxic and side effects.
SMARCA DEGRADERS AND USES THEREOF
-
Paragraph 00835; 00836, (2020/12/30)
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same for the modulation of one or more SWI/SNF-related matrix associated actin dependent regulator of chromatin subfamily A (SMARCA) and/or polybromo-1 (PB-1) protein via ubiqitination and/or degradation by compounds. The compounds are bifunctional molecules that link a cereblon-binding moiety to a ligand that binds SMARCA and/or PB1 proteins.
PYRIDAZINONES AS PARP7 INHIBITORS
-
Paragraph 0937, (2019/11/11)
The present invention relates to pyridazinones and related compounds which are inhibitors of PARP7 and are useful in the treatment of cancer.